Tempest Therapeutics's market cap is currently $40.34M. The company's EPS TTM is $-1.536; its P/E ratio is ―; Tempest Therapeutics is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -381.00K	$ -1.81M	$ -1.27M	$ -815.00K	$ -1.05M
Operating Income	$ -29.16M	$ -34.64M	$ -26.99M	$ -19.30M	$ -45.40M
EBITDA	$ -28.78M	$ -32.28M	$ -25.72M	$ -18.39M	$ -43.52M
Net Income	$ -29.49M	$ -36.78M	$ -29.55M	$ -19.12M	$ -44.57M
Balance Sheet
Cash & Short-Term Investments	$ 39.23M	$ 31.23M	$ 51.83M	$ 18.82M	$ 63.51M
Total Assets	$ 51.60M	$ 46.09M	$ 73.24M	$ 22.86M	$ 74.97M
Total Debt	$ 20.66M	$ 22.11M	$ 18.54M	$ 2.44M	$ 4.52M
Net Debt	$ -18.57M	$ -9.12M	$ -33.29M	$ -16.38M	$ -58.99M
Total Liabilities	$ 24.84M	$ 27.98M	$ 37.12M	$ 91.66M	$ 15.10M
Stockholders' Equity	$ 26.77M	$ 18.11M	$ 36.12M	$ -68.79M	$ 58.55M
Cash Flow
Free Cash Flow	$ -27.53M	$ -31.63M	$ -26.09M	$ -19.07M	$ -41.62M
Operating Cash Flow	$ -27.36M	$ -31.07M	$ -25.96M	$ -19.02M	$ -41.22M
Investing Cash Flow	$ -170.00K	$ -562.00K	$ -97.00K	$ -6.00K	$ 3.99M
Financing Cash Flow	$ 35.60M	$ 11.40M	$ 59.06M	$ 34.60M	$ 26.94M

Currency in USD

Tempest Therapeutics Earnings and Revenue History

Income Statement >

Tempest Therapeutics Debt to Assets

Balance Sheet >

Tempest Therapeutics Cash Flow

Cash Flow >

Tempest Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing